Alert: Negative Investment/Fundamental Signals (3/1/24)-Ironwood Pharmaceuticals Inc (NASDAQ: IRWD)

out_logo_500#64135.jpg

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) has recently experienced significant negative changes in fundamentals: the consensus estimate for December, 2024 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2025 decreased significantly.

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) has recently experienced extremely meaningful negative changes in investment behavior: negative upside/downside volume developed, and the stock fell on very heavy volume.

The stock is currently unrated.

out_mm#64135.jpg

Current PriceTarget Research Rating

Reflecting future returns on capital that are forecasted to fall short of the cost of capital, IRWD is expected to be a major Value Eraser.

Ironwood Pharmaceuticals is currently unrated.

Recent Price Action

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) stock declined by -3.9% on 3/1/24. The shares closed at $9.06. Moreover, exceptionally high trading volume at 388% of normal accompanied the decline. The stock has been exceptionally strong relative to the market over the last nine months but has declined -39.0% during the last week.

Be the first to comment

Leave a Reply

Your email address will not be published.


*